Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 24,929 shares at $141.84 ($3.5M) on 2016-11-04, disclosed to the SEC on 2016-11-07.
Seasonal sale ($3.5M) by Director — this insider has traded ALXN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.98 | 11,838 | $1.7M | 47.1% |
| 2 | $140.83 | 8,521 | $1.2M | 34.1% |
| 3 | $141.84 | 831 | $118K | 3.4% |
| 4 | $145.06 | 3,739 | $542K | 15.4% |
| Total | $141.09 avg | 24,929 | $3.5M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |